18 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Corvus Pharmaceuticals, Inc. CRVS stock moved upwards by 97.44% to $5.41 during Tuesday's pre-market session.

• Endologix, Inc. ELGX stock moved upwards by 45.55% to $0.37. According to the most recent rating by BTIG, on May 12, the current rating is at Neutral.

• AEterna Zentaris, Inc. AEZS stock moved upwards by 39.32% to $0.58.

• Novavax, Inc. NVAX shares rose 35.44% to $107.60. The most recent rating by B. Riley FBR, on Jun 29, is at Buy, with a price target of $106.

• Endo International, Inc. ENDP shares rose 17.56% to $4.25. The most recent rating by Piper Sandler, on Apr 15, is at Overweight, with a price target of $6.

• ObsEva, Inc. OBSV shares increased by 14.02% to $3.70. The most recent rating by BMO Capital, on Jul 7, is at Market Perform, with a price target of $4.

• Vaxart, Inc. VXRT stock moved upwards by 13.35% to $7.30. The most recent rating by HC Wainwright & Co., on Apr 30, is at Buy, with a price target of $7.

• Otonomy, Inc. OTIC stock increased by 12.57% to $3.58. The most recent rating by Cantor Fitzgerald, on Jun 16, is at Overweight, with a price target of $9.

• BELLUS Health, Inc. BLU shares rose 9.11% to $3.71. The most recent rating by HC Wainwright & Co., on Jun 26, is at Buy, with a price target of $28.

• Livongo Health, Inc. LVGO shares rose 7.92% to $83.78. The most recent rating by Stephens & Co., on Jul 7, is at Overweight, with a price target of $95.

Losers

• Evolus, Inc. EOLS shares fell 39.85% to $3.20 during Tuesday's pre-market session. The most recent rating by Mizuho, on May 12, is at Buy, with a price target of $8.

• Unum Therapeutics, Inc. UMRX stock fell 17.73% to $1.81.

• Cellectis, Inc. CLLS shares declined 15.44% to $16.11.

• Aptorum Group, Inc. APM stock decreased by 6.67% to $3.36.

• resTORbio, Inc. TORC stock decreased by 5.23% to $2.36. The most recent rating by Evercore ISI Group, on Apr 30, is at Outperform, with a price target of $4.

• Lianluo Smart, Inc. LLIT shares fell 4.37% to $0.66.

• 9 Meters Biopharma, Inc. NMTR stock fell 3.48% to $0.60.

• HTG Molecular Diagnostics, Inc. HTGM shares declined 3.23% to $0.60. The most recent rating by HC Wainwright & Co., on May 14, is at Buy, with a price target of $1.